LINDAHL RICHARD S
SEC CIK 1196632 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | EVP, CFO | 374.1K | $112.4K | — | 28 | 2021-11-15 | 2026-06-08 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
| 15 | LINDAHL RICHARD S | EVP, CFO | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 15:08 | 2026-06-08 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.00 | -3,964 | 374.1K | -1% | -$31.7K | |
| 2026-05-01 16:27 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +162.7K | 378.0K | +76% | $0 | |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.44 | -23.6K | 215.4K | -10% | -$199.6K |
| 2026-03-03 | 2026-03-01 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.15 | -683 | 239.0K | -0.3% | -$5,566 | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | D - Sale to Iss | $10.92 | -46.2K | 245.3K | -16% | -$504.0K | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $10.92 | -5,642 | 239.7K | -2% | -$61.6K | |
| 2025-10-17 | 2025-10-15 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $9.60 | -4,995 | 291.5K | -2% | -$48.0K | |
| 2025-06-10 | 2025-06-08 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $6.63 | -2,733 | 296.5K | -0.9% | -$18.1K | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +146.9K | 299.2K | +96% | $0 |
| 2025-03-04 | 2025-02-12 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | D - Sale to Iss | $0.00 | -16.9K | 154.1K | -10% | $0 | |
| M | 2025-03-04 | 2025-02-28+ | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $7.48 | -1,756 | 153.0K | -1% | -$13.1K |
| 2024-10-17 | 2024-10-15 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +15.0K | 171.0K | +10% | $0 | |
| 2024-06-11 | 2024-06-08 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $6.19 | -2,733 | 156.0K | -2% | -$16.9K | |
| M | 2024-03-04 | 2024-02-29+ | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $3.24 | -9,721 | 158.7K | -6% | -$31.5K |
| 2024-02-27 | 2024-02-21 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | D - Sale to Iss | $2.71 | -4,012 | 169.0K | -2% | -$10.9K | |
| 2024-02-27 | 2024-02-23 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $2.74 | -517 | 168.5K | -0.3% | -$1,417 | |
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +73.8K | 123.8K | +148% | $0 |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +18.5K | 86.8K | +27% | $0 |
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $12.38 | -1,074 | 16.9K | -6% | -$13.3K | |
| M | 2023-02-27 | 2023-02-23+ | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $13.89 | -1,421 | 18.0K | -7% | -$19.7K |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +101 | 21.8K | +0.5% | $0 | |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $13.25 | -2,396 | 19.4K | -11% | -$31.7K | |
| DM | 2022-03-02 | 2022-03-01 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +48.3K | 86.3K | +127% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $39.64 | -818 | 85.5K | -0.9% | -$32.4K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $42.39 | -1,499 | 38.0K | -4% | -$63.5K |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +1,836 | 41.8K | +5% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | F - Tax | $42.23 | -2,298 | 39.5K | -6% | -$97.0K | |
| 2021-11-15 | 2021-11-15 | EBS | Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, CFO | P - Purchase | $37.46 | +3,000 | 39.9K | +8% | +$112.4K |
Purchase Sale Sale after option exercise All abbreviations